BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210611
DTSTAMP:20260515T190245
CREATED:20210203T103911Z
LAST-MODIFIED:20210203T103911Z
UID:28763-1623110400-1623369599@www.pharmajournalist.com
SUMMARY:TCR-based Therapies Summit
DESCRIPTION:The TCR-based Therapies Summit is Dedicated to Supercharging TCR Design\, Translation & Manufacturing Strategy for Solid Tumor Success\nRunning digitally for 2021\, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity\, density & binding affinity for solid tumor indications. \n \nThis June (8-10)\, join this exclusive community online to virtually network and learn from the leading experts in pharma\, biotech and academia\, as we discuss how to how to overcome on-target off-tumor toxicity\, enhance the binding affinity and avidity of TCR-T therapies and utilize dual targeting and combination approaches for enhanced efficacy. \nNavigate across 3 days packed with dedicated\, interactive formats exploring the identification of novel targets\, the importance of safety profiling\, and discuss optimization of soluble approaches for the development of next-generation TCR-T products. \nFor more details about the program\, speaker faculty or pricing and discounts\, download the brochure. \nHelping Deliver Best-In-Class TCR Therapies\nJoin experts as they discuss the design\, efficacy and clinical development of TCR therapeutics for solid tumor indications and beyond. \n\nOptimizeyour TCR therapy approach\nExplorenovel combination strategies\nArmyour cells against the hostile tumor microenvironment\nImprovetarget selection and off-target validation\nExplorethe future of manufacturing for next-generation TCRs\n\n“Hanson Wade’s CAR-TCR summit has been already the leading specialized conference in the field – what a great suggestion to set up a dedicated forum for the rapidly growing TCR-T area.” \nSteffen Walter\, Chief Scientific Office\, Immatics US
URL:https://www.pharmajournalist.com/event/tcr-based-therapies-summit/
LOCATION:EST | Digital
ORGANIZER;CN="Hansonwade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210608
DTEND;VALUE=DATE:20210611
DTSTAMP:20260515T190245
CREATED:20210312T065317Z
LAST-MODIFIED:20210312T065317Z
UID:29307-1623110400-1623369599@www.pharmajournalist.com
SUMMARY:Next Generation Gene Therapy Vectors
DESCRIPTION:The inaugural Next Generation Gene Therapy Vectors meeting is dedicated to overcoming the current immunogenicity\, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors. \n \nIndustry pioneers from cutting edge biotechs and world-leading academic vectorology groups including Dyno Therapeutics\, 4D Molecular Therapeutics and Generation Bio will share how ever-increasing clinical experience is guiding strategies to decrease the immunogenicity of vectors to allow durable transgene expression\, engineer vectors with lower toxicity at higher doses and use innovative technologies to optimise capsid\, transgene\, and promoter design. \nEverything in gene therapy starts with the vector\, so join this definitive\, niche\, digital conference to delve into the details of vector design\, engineering\, and optimization case studies\, equipping you with the insights required to deliver transformative therapeutics to patients more effectively and safely than ever before. \nTo know more about Next Generation Gene Therapy Vectors please click here.
URL:https://www.pharmajournalist.com/event/next-generation-gene-therapy-vectors/
LOCATION:Virtual Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR